Logo image of LIFE.OL

LIFECARE ASA (LIFE.OL) Stock Fundamental Analysis

Europe - Euronext Oslo - OSL:LIFE - NO0013355859 - Common Stock

4.08 NOK
+0.02 (+0.49%)
Last: 12/19/2025, 7:00:00 PM
Fundamental Rating

3

LIFE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 65 industry peers in the Health Care Equipment & Supplies industry. The financial health of LIFE is average, but there are quite some concerns on its profitability. LIFE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LIFE has reported negative net income.
In the past year LIFE has reported a negative cash flow from operations.
In the past 5 years LIFE always reported negative net income.
In the past 5 years LIFE always reported negative operating cash flow.
LIFE.OL Yearly Net Income VS EBIT VS OCF VS FCFLIFE.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

LIFE has a worse Return On Assets (-93.35%) than 93.85% of its industry peers.
The Return On Equity of LIFE (-124.42%) is worse than 83.08% of its industry peers.
Industry RankSector Rank
ROA -93.35%
ROE -124.42%
ROIC N/A
ROA(3y)-42.61%
ROA(5y)-38.99%
ROE(3y)-60.35%
ROE(5y)-53.22%
ROIC(3y)N/A
ROIC(5y)N/A
LIFE.OL Yearly ROA, ROE, ROICLIFE.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LIFE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LIFE.OL Yearly Profit, Operating, Gross MarginsLIFE.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800

More info and screens

5

2. Health

2.1 Basic Checks

LIFE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LIFE has more shares outstanding
Compared to 5 years ago, LIFE has less shares outstanding
The debt/assets ratio for LIFE has been reduced compared to a year ago.
LIFE.OL Yearly Shares OutstandingLIFE.OL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
LIFE.OL Yearly Total Debt VS Total AssetsLIFE.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -2.03, we must say that LIFE is in the distress zone and has some risk of bankruptcy.
LIFE's Altman-Z score of -2.03 is on the low side compared to the rest of the industry. LIFE is outperformed by 83.08% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that LIFE is not too dependend on debt financing.
LIFE's Debt to Equity ratio of 0.12 is fine compared to the rest of the industry. LIFE outperforms 73.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z -2.03
ROIC/WACCN/A
WACC7.76%
LIFE.OL Yearly LT Debt VS Equity VS FCFLIFE.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

A Current Ratio of 3.34 indicates that LIFE has no problem at all paying its short term obligations.
The Current ratio of LIFE (3.34) is better than 87.69% of its industry peers.
A Quick Ratio of 3.34 indicates that LIFE has no problem at all paying its short term obligations.
LIFE has a Quick ratio of 3.34. This is amongst the best in the industry. LIFE outperforms 92.31% of its industry peers.
Industry RankSector Rank
Current Ratio 3.34
Quick Ratio 3.34
LIFE.OL Yearly Current Assets VS Current LiabilitesLIFE.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for LIFE have decreased strongly by -40.55% in the last year.
LIFE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -26.10%.
The Revenue has been growing by 36.13% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-40.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)-26.1%
Revenue growth 3Y82.19%
Revenue growth 5Y36.13%
Sales Q2Q%-99.89%

3.2 Future

Based on estimates for the next years, LIFE will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.88% on average per year.
Based on estimates for the next years, LIFE will show a very strong growth in Revenue. The Revenue will grow by 53.02% on average per year.
EPS Next Y8.12%
EPS Next 2Y10.07%
EPS Next 3Y8.88%
EPS Next 5YN/A
Revenue Next Year-75%
Revenue Next 2Y15.47%
Revenue Next 3Y53.03%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LIFE.OL Yearly Revenue VS EstimatesLIFE.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
LIFE.OL Yearly EPS VS EstimatesLIFE.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 -1 -2 -3 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LIFE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LIFE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LIFE.OL Price Earnings VS Forward Price EarningsLIFE.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LIFE.OL Per share dataLIFE.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.07%
EPS Next 3Y8.88%

More info and screens

0

5. Dividend

5.1 Amount

LIFE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

LIFECARE ASA

OSL:LIFE (12/19/2025, 7:00:00 PM)

4.08

+0.02 (+0.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-27 2024-08-27/bmo
Earnings (Next)N/A N/A
Inst Owners7.56%
Inst Owner ChangeN/A
Ins Owners7.41%
Ins Owner ChangeN/A
Market Cap77.76M
Revenue(TTM)2.83M
Net Income(TTM)-73.93M
AnalystsN/A
Price Target36.72 (800%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)4.23%
EPS NY rev (3m)4.23%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-50%
Revenue NY rev (3m)-50%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 27.47
P/FCF N/A
P/OCF N/A
P/B 1.31
P/tB 1.64
EV/EBITDA N/A
EPS(TTM)-16.64
EYN/A
EPS(NY)-3.76
Fwd EYN/A
FCF(TTM)-4.2
FCFYN/A
OCF(TTM)-3.63
OCFYN/A
SpS0.15
BVpS3.12
TBVpS2.48
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -93.35%
ROE -124.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-42.61%
ROA(5y)-38.99%
ROE(3y)-60.35%
ROE(5y)-53.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 192.06%
Cap/Sales 386.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.34
Quick Ratio 3.34
Altman-Z -2.03
F-Score1
WACC7.76%
ROIC/WACCN/A
Cap/Depr(3y)168.09%
Cap/Depr(5y)N/A
Cap/Sales(3y)55.69%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y8.12%
EPS Next 2Y10.07%
EPS Next 3Y8.88%
EPS Next 5YN/A
Revenue 1Y (TTM)-26.1%
Revenue growth 3Y82.19%
Revenue growth 5Y36.13%
Sales Q2Q%-99.89%
Revenue Next Year-75%
Revenue Next 2Y15.47%
Revenue Next 3Y53.03%
Revenue Next 5YN/A
EBIT growth 1Y-139.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5.41%
EBIT Next 3Y6.74%
EBIT Next 5YN/A
FCF growth 1Y-189.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-164.06%
OCF growth 3YN/A
OCF growth 5YN/A

LIFECARE ASA / LIFE.OL FAQ

What is the ChartMill fundamental rating of LIFECARE ASA (LIFE.OL) stock?

ChartMill assigns a fundamental rating of 3 / 10 to LIFE.OL.


What is the valuation status for LIFE stock?

ChartMill assigns a valuation rating of 0 / 10 to LIFECARE ASA (LIFE.OL). This can be considered as Overvalued.


How profitable is LIFECARE ASA (LIFE.OL) stock?

LIFECARE ASA (LIFE.OL) has a profitability rating of 0 / 10.


Can you provide the financial health for LIFE stock?

The financial health rating of LIFECARE ASA (LIFE.OL) is 5 / 10.